Tosun Nicole, Lee Ryan, Crevel Francoise, McKenzie Carrie, Odlaug Brian, Bellin Melena D, Prich Brenda, Weisdorf Daniel
Clinical Research Support Center | Clinical & Translational Science Institute, University of Minnesota, 505 Essex St SE, Minneapolis, MN 55455.
Department of Neurology, University of Minnesota, Minneapolis, MN 55455.
J Res Adm. 2022 Fall;53(2):103-118.
To successfully and efficiently initiate clinical research studies, it is critical to develop a strong, feasible, and well-written study protocol early in the start-up phase. The University of Minnesota's Clinical Research Support Center designed and implemented a structured Feasibility Review process in 2018 that addresses common start-up challenges such as poor study design, inappropriate outcomes, and limited resources. This process has been shown to turn an unfeasible study into a well-designed protocol that is IRB-approved with few protocol-related stipulations and well prepared for execution. It has also educated study teams on how to write better quality and more robust protocols for subsequent studies. Once a draft protocol is available, the entire process takes just six working days and is free of charge to investigators, study teams, and departments. From 2018-2021, one hundred sixteen Feasibility Reviews (n=116) have been completed across eight schools or colleges. Mean satisfaction scores for study team members who responded were high (N=126, M=4.71 ± 0.5) on a 5-point Likert-type scale. Most respondents (96%) indicated that they planned to modify their protocol based on reviewer feedback. Open ended/qualitative feedback was highly positive with most responses centered around the helpfulness of feasibility review, the high level of expertise, and fast turnaround time. The Feasibility Review is a valuable and multifunctional program providing timely expert guidance to study teams to efficiently and successfully launch and execute clinical research studies. It can be easily replicated, adapted, and implemented at other institutions to increase the quality and efficacy of academic research.
为了成功且高效地启动临床研究,在启动阶段尽早制定一个强有力、可行且撰写精良的研究方案至关重要。明尼苏达大学临床研究支持中心于2018年设计并实施了一个结构化的可行性审查流程,该流程解决了诸如研究设计不佳、结果不合适以及资源有限等常见的启动挑战。事实证明,这个流程能将一个不可行的研究转变为一个设计良好、经机构审查委员会批准且几乎没有与方案相关规定的方案,并为执行做好充分准备。它还让研究团队了解了如何为后续研究撰写质量更高、更完善的方案。一旦有了方案草案,整个流程只需六个工作日,且对研究者、研究团队和部门免费。从2018年到2021年,在八所学校或学院共完成了116次可行性审查。在5分制的李克特量表上,做出回应的研究团队成员的平均满意度得分很高(N = 126,M = 4.71 ± 0.5)。大多数受访者(96%)表示他们计划根据审查者的反馈修改方案。开放式/定性反馈非常积极,大多数回应集中在可行性审查的帮助性、高水平的专业知识以及快速周转时间上。可行性审查是一个有价值且多功能的项目,为研究团队提供及时的专家指导,以高效且成功地启动和执行临床研究。它可以很容易地在其他机构复制、调整和实施,以提高学术研究的质量和效果。